IllnessRett-like syndrome, differential diagnosis
Summary
Comprehensive differential diagnostic panel for Rett-like syndrome comprising 1 guideline-curated core gene, 9 core candidate genes and altogether 56 curated genes according to the clinical signs
153,9 kb (Extended panel: incl. additional genes)
- EDTA-anticoagulated blood (3-5 ml)
NGS +
[Sanger]
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
ARX | 1689 | NM_139058.3 | XL | |
CDKL5 | 3093 | NM_003159.3 | XL | |
FOXG1 | 1470 | NM_005249.5 | AD | |
MECP2 | 1461 | NM_004992.4 | XL | |
MEF2C | 1422 | NM_002397.5 | AD | |
SCN2A | 6018 | NM_021007.3 | AD | |
STXBP1 | 1812 | NM_003165.6 | AD, AR | |
UBE3A | 2559 | NM_130838.4 | AD | |
WDR45 | 1086 | NM_007075.4 | XL | |
ZEB2 | 3645 | NM_014795.4 | AD | |
CNPY3 | 837 | NM_006586.5 | AR | |
CUX2 | 4461 | NM_015267.4 | AD | |
DENND5A | 3864 | NM_015213.4 | AR | |
DNM1 | 2595 | NM_004408.4 | AD | |
DOCK7 | 6390 | NM_001271999.2 | AR | |
EEF1A2 | 1392 | NM_001958.5 | AD | |
FRRS1L | 1035 | NM_014334.4 | AR | |
GABBR2 | 2826 | NM_005458.8 | AD | |
GABRA1 | 1371 | NM_000806.5 | AD | |
GABRA2 | 1356 | NM_001114175.3 | AD | |
GABRB3 | 1422 | NM_000814.6 | AD | |
GABRG2 | 1404 | NM_000816.3 | AD | |
GNAO1 | 1065 | NM_020988.3 | AD | |
GRIN2B | 4455 | NM_000834.5 | AD | |
HCN1 | 2673 | NM_021072.4 | AD | |
HNRNPU | 2478 | NM_031844.3 | AD | |
ITPA | 585 | NM_033453.4 | AR | |
KCNA2 | 1500 | NM_004974.4 | AD | |
KCNB1 | 2577 | NM_004975.4 | AD | |
KCNQ2 | 2619 | NM_172107.4 | AD | |
KCNT1 | 3708 | NM_020822.3 | AD | |
MDH2 | 1017 | NM_005918.4 | AR | |
NTRK2 | 2517 | NM_006180.6 | AD | |
PARS2 | 1428 | NM_152268.4 | AR | |
PCDH19 | 3447 | NM_001184880.2 | XL | |
PHACTR1 | 1743 | NM_001242648.4 | AD | |
PIGQ | 1746 | NM_004204.5 | AR | |
PLCB1 | 3651 | NM_015192.4 | AR | |
SCN1A | 6030 | NM_001165963.4 | AD | |
SCN1B | 657 | NM_001037.5 | AD, AR | |
SCN3A | 6003 | NM_006922.4 | AD | |
SCN8A | 5943 | NM_014191.4 | AD | |
SLC12A5 | 3351 | NM_020708.5 | AD, AR | |
SLC13A5 | 1707 | NM_177550.5 | AR | |
SLC1A2 | 1725 | NM_004171.4 | AD | |
SLC25A12 | 2037 | NM_003705.5 | AR | |
SLC25A22 | 972 | NM_024698.6 | AR, AD | |
SPTAN1 | 7434 | NM_001130438.3 | AD | |
ST3GAL3 | 1128 | NM_006279.5 | AR | |
SYNGAP1 | 4032 | NM_006772.3 | AD | |
SYNJ1 | 4839 | NM_003895.3 | AR | |
SZT2 | 10128 | NM_015284.4 | AR | |
TBC1D24 | 1680 | NM_001199107.2 | AR | |
TRAK1 | 2862 | NM_001042646.3 | AR | |
WASF1 | 1688 | NM_003931.3 | AD | |
WWOX | 1245 | NM_016373.4 | AR |
Informations about the disease
Rett-like or Rett-variant syndrome has a broader clinical spectrum than classic Rett syndrome in females. This ranges from mild learning difficulties to severe neonatal encephalopathy or Parkinsonism or severe syndromic psychomotor retardation. The symptoms therefore appear early, and the different inheritance patterns depend on the gene (or genes) involved. Even by means of extensive panel examinations with several dozen genes, depending on the clinical clarification, no simple genetic cause can be found in some patients.
Reference: https://www.ncbi.nlm.nih.gov/books/NBK1497/
- Sympt.: Autism, dementia, ataxia, loss of purposeful hand use
- Sympt.: Developmental decline, speech loss, stereotypic movements hands, microcephaly, seizures, MR
- Alias: Rett syndrome, atypical
- Allelic: Autism susceptibility, XL 3 (MECP2)
- Allelic: Brugada syndrome 5 (SCN1B)
- Allelic: Chromosome 5q14.3 deletion syndrome (MEF2C)
- Allelic: DOORS syndrome (TBC1D24)
- Allelic: Deafness , Ar 86 (TBC1D24)
- Allelic: Deafness, AD 65 (TBC1D24)
- Allelic: Encephalopathy, neonatal severe (MECP2)
- Allelic: Epilepsy, familial focal, with variable foci 4 (SCN3A)
- Allelic: Epilepsy, generalized, with febrile seizures plus, type 1 (SCN1B)
- Allelic: Epilepsy, generalized, with febrile seizures plus, type 2 (SCN1A)
- Allelic: Epilepsy, generalized, with febrile seizures plus, type 3 (GABRG2)
- Allelic: Epilepsy, nocturnal frontal lobe, 5 (KCNT1)
- Allelic: Epilepsy, rolandic, with proxysmal exercise-induce dystonia + writer's cramp (TBC1D24)
- Allelic: Episodic ataxia, type 9 (SCN2A)
- Allelic: Esophageal squamous cell carcinoma, somatic (WWOX)
- Allelic: Febrile seizures, familial, 3A (SCN1A)
- Allelic: Febrile seizures, familial, 8 (GABRG2)
- Allelic: Generalized epilepsy with febrile seizures plus, type 10 (HCN1)
- Allelic: Hydranencephaly with abnormal genitalia (ARX)
- Allelic: Lissencephaly, XL 2 (ARX)
- Allelic: Mental retardation, AD 38 (EEF1A2)
- Allelic: Mental retardation, AD 6 (GRIN2B)
- Allelic: Mental retardation, AR 12 (ST3GAL3)
- Allelic: Mental retardation, XL 29 + others (ARX)
- Allelic: Mental retardation, XL syndromic, Lubs type (MECP2)
- Allelic: Mental retardation, XL, syndromic 13 (MECP2)
- Allelic: Migraine, familial hemiplegic, 3 (SCN1A)
- Allelic: Myoclonic epilepsy, infantile, familial (TBC1D24)
- Allelic: Myokymia (KCNQ2)
- Allelic: Obesity, hyperphagia + developmental delay (NTRK2)
- Allelic: Parkinson disease 20, early-onset (SYNJ1)
- Allelic: Seizures, benign familial infantile, 3 (SCN2A)
- Allelic: Seizures, benign familial infantile, 5 (SCN8A)
- Allelic: Seizures, benign neonatal, 1 (KCNQ2)
- Allelic: Spinocerebellar ataxia, AR 12 (WWOX)
- Angelman syndrome (UBE3A)
- Chromosome 5q14.3 deletion syndrome (MEF2C)
- Epileptic encephalopathy, early infantile, 1 (ARX)
- Epileptic encephalopathy, early infantile, 11 (SCN2A)
- Epileptic encephalopathy, early infantile, 12 (PLCB1)
- Epileptic encephalopathy, early infantile, 13 (SCN8A)
- Epileptic encephalopathy, early infantile, 14 (KCNT1)
- Epileptic encephalopathy, early infantile, 15 (ST3GAL3)
- Epileptic encephalopathy, early infantile, 16 (TBC1D24)
- Epileptic encephalopathy, early infantile, 17 (GNAO1)
- Epileptic encephalopathy, early infantile, 18 (SZT2)
- Epileptic encephalopathy, early infantile, 19 (GABRA1)
- Epileptic encephalopathy, early infantile, 2 (CDKL5)
- Epileptic encephalopathy, early infantile, 23 (DOCK7)
- Epileptic encephalopathy, early infantile, 24 (HCN1)
- Epileptic encephalopathy, early infantile, 25 (SLC13A5)
- Epileptic encephalopathy, early infantile, 26 (KCNB1)
- Epileptic encephalopathy, early infantile, 27 (GRIN2B)
- Epileptic encephalopathy, early infantile, 28 (WWOX)
- Epileptic encephalopathy, early infantile, 3 (SLC25A22)
- Epileptic encephalopathy, early infantile, 31 (DNM1)
- Epileptic encephalopathy, early infantile, 32 (KCNA2)
- Epileptic encephalopathy, early infantile, 33 (EEF1A2)
- Epileptic encephalopathy, early infantile, 34 (SLC12A5)
- Epileptic encephalopathy, early infantile, 35 (ITPA)
- Epileptic encephalopathy, early infantile, 37 (FRRS1L)
- Epileptic encephalopathy, early infantile, 39 /SLC25A12)
- Epileptic encephalopathy, early infantile, 4 (STXBP1)
- Epileptic encephalopathy, early infantile, 41 (SLC1A2)
- Epileptic encephalopathy, early infantile, 43 (GABRB3)
- Epileptic encephalopathy, early infantile, 49 (DENND5A)
- Epileptic encephalopathy, early infantile, 5 (SPTAN1)
- Epileptic encephalopathy, early infantile, 51 (MDH2)
- Epileptic encephalopathy, early infantile, 52 (SCN1B)
- Epileptic encephalopathy, early infantile, 53 (SYNJ1)
- Epileptic encephalopathy, early infantile, 54 (HNRNPU)
- Epileptic encephalopathy, early infantile, 58 (NTRK2)
- Epileptic encephalopathy, early infantile, 59 (GABBR2)
- Epileptic encephalopathy, early infantile, 6 [Dravet syndrome] (SCN1A)
- Epileptic encephalopathy, early infantile, 60 (CNPY3)
- Epileptic encephalopathy, early infantile, 62 (SCN3A)
- Epileptic encephalopathy, early infantile, 67 (CUX2)
- Epileptic encephalopathy, early infantile, 68 (TRAK1)
- Epileptic encephalopathy, early infantile, 7 (KCNQ2)
- Epileptic encephalopathy, early infantile, 70 (PHACTR1)
- Epileptic encephalopathy, early infantile, 74 (GABRG2)
- Epileptic encephalopathy, early infantile, 75 (PARS2)
- Epileptic encephalopathy, early infantile, 77 (PIGQ)
- Epileptic encephalopathy, early infantile, 78 (GABRA2)
- Epileptic encephalopathy, early infantile, 9 (PCDH19)
- Mental retardation, AD 5 (SYNGAP1)
- Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations (MEF2C)
- Mowat-Wilson syndrome (ZEB2)
- Neurodegeneration with brain iron accumulation 5 (WDR45)
- Neurodevelopmental disorder with involuntary movements (GNAO1)
- Neurodevelopmental disorder with poor language + loss of hand skills (GABBR2)
- Partington syndrome (ARX)
- Proud syndrome (ARX)
- Rett syndrome (MECP2)
- Rett syndrome, atypical (MECP2)
- Rett syndrome, congenital variant (FOXG1)
- Rett syndrome, preserved speech variant (MECP2)
- AD
- AR
- XL
- Multiple OMIM-Ps
Bioinformatics and clinical interpretation
Test-Stärken
- DAkkS-akkreditiertes Labor
- EU-Richtlinie für IVD in Umsetzung
- Qualitäts-kontrolliert arbeitendes Personal
- Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
- Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
- eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
- unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
- unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
- unsere umfassenden klinischen Aussagen
Testeinschränkungen
- Gene mit eingeschränkter Abdeckung werden gekennzeichnet
- Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
- es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
- die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
- Gen-Konversionen
- komplexe Inversionen
- Balancierte Translokationen
- Mitochondriale Varianten
- Repeat-Expansionen, sofern nicht anders dokumentiert
- nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
- niedriger Mosaik-Status
- Repeat-Blöcke von Mononukleotiden
- Indels >50bp (Insertionen-Deletionen)
- Deletionen oder Duplikationen einzelner Exons
- Varianten innerhalb von Pseudogenen
- die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde
Laboratory requirement
Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.
Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.
Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.
Die Untersuchung wird auch für Selbstzahler angeboten.